Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained

October 5, 2026 9:29 AM

UBS analyst Ashwani Verma raised the price target on Incyte (NASDAQ: INCY) to $127.00 (from $113.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained

Categories